Prostate Cancer — Guide Hub
Prostate cancer is one of the most common cancers in men, often detected through screening tests or investigation of urinary symptoms.
This hub connects guides on prevention, diagnosis, treatment choices, and long-term care.
Prostate Cancer by the Numbers
- 1.4 million new cases each year globally (WHO, 2024).
- Second most common cancer in men worldwide.
- 375,000 deaths annually.
- Lifetime risk: ~1 in 8 men in developed countries.
- 5-year survival: >95% in early/localized stages, <30% in advanced disease.
Core Guides
- Prostate Cancer Risk Factors
- Prostate Cancer Screening — PSA and Beyond
- Prostate Cancer Treatment Options
- Life After Prostate Cancer: Survivorship and Support
FAQ
Q: What is prostate cancer?
A: Abnormal growth of prostate gland cells, one of the most common cancers in men.
Q: How common is it?
A: Over 1.4 million new cases annually, second only to lung cancer in men.
Q: Who is at risk?
A: Older men, those with family history, African or Caribbean ancestry, or BRCA mutations.
Q: Can it be prevented?
A: Not completely, but lifestyle changes and regular screening help.
Related Guides
- Cancer — Guide Hub — overview of cancer types, treatment approaches, and survivorship.
- Genetic Testing — BRCA2 mutations are a known risk factor for prostate cancer; hereditary testing context.
- Testing and Screening — PSA testing, biopsy, and how to interpret cancer screening results.
- Heart & Circulation Hub — prostate cancer treatments (androgen deprivation therapy) carry significant cardiovascular implications.
- Bowel Cancer — cancer screening principles and survivorship across cancer types.
- Skin Cancer — early detection strategies applicable across cancer types.
- Smoking Cessation — smoking is associated with more aggressive prostate cancer outcomes.
Last reviewed: September 17, 2025
Educational only; not a substitute for professional medical advice.